Publicaciones en colaboración con investigadores/as de Hospital Infanta Sofia (51)

2023

  1. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

    Frontiers in Immunology, Vol. 14

  2. Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

    BMC Cancer, Vol. 23, Núm. 1

  3. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review

    Current Oncology, Vol. 30, Núm. 10, pp. 9335-9345

  4. M-Health in lung cancer: A literature review

    SAGE Open Medicine, Vol. 11

  5. The mHealth ALIBIRD Platform: Supporting Cancer Patient Treatment and Follow-up

    Proceedings - IEEE Symposium on Computer-Based Medical Systems

2021

  1. Immune checkpoint inhibitors in endometrial cancer

    Critical Reviews in Oncology/Hematology, Vol. 161

  2. Metabolic health together with a lipid genetic risk score predicts survival of small cell lung cancer patients

    Cancers, Vol. 13, Núm. 5, pp. 1-8

2020

  1. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?

    Lung Cancer

  2. Adjuvant chemotherapy in endometrial cancer

    Cancer Chemotherapy and Pharmacology, Vol. 85, Núm. 3, pp. 477-486

  3. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer

    Molecular Oncology, Vol. 14, Núm. 12, pp. 3135-3152

2019

  1. Erratum to “Lipid metabolism and lung cancer” [Crit. Rev. Oncol. Hematol. 112, April (2017), 31–40](S1040842817300513)(10.1016/j.critrevonc.2017.02.001)

    Critical Reviews in Oncology/Hematology

2018

  1. Antinuclear antibodies and cancer: A literature review

    Critical Reviews in Oncology/Hematology, Vol. 127, pp. 42-49

2017

  1. Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial

    Tumor Biology, Vol. 39, Núm. 6

  2. Lipid metabolism and lung cancer

    Critical Reviews in Oncology/Hematology, Vol. 112, pp. 31-40

  3. Process improvement in an oncology day hospital: Design of a traceability and indicator system

    HEALTHINF 2017 - 10th International Conference on Health Informatics, Proceedings; Part of 10th International Joint Conference on Biomedical Engineering Systems and Technologies, BIOSTEC 2017

2016

  1. Cetuximab. Erbitux®

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 95-102

  2. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives

    Critical Reviews in Oncology/Hematology, Vol. 107, pp. 54-71

  3. Panitumumab. Vectibix®

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 299-306

2015

  1. Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer

    PLoS ONE, Vol. 10, Núm. 1

2014

  1. Application of novel genotyping microarray technologies in cancer research

    Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 47-73